Abstract
The diseases caused by the trypanosomatid parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania are widely distributed throughout the world. Because of the toxic side-effects and the economically unviable cost of the currently used pharmaceutical treatments, the search for new drug targets continues. Since the antioxidant metabolism in these parasites relies on trypanothione [T(SH)2], a functional analog of glutathione, most of the pathway enzymes involved in its synthesis, utilization and reduction have been proposed as drug targets for therapeutic intervention. In the present review, the antioxidant metabolism and the phenotypic effects of inhibiting by genetic (RNA interference, knockout) or chemical approaches, the T(SH)2 and polyamine pathway enzymes in the parasites are analyzed. Although the genetic strategies are helpful in identifying essential genes for parasite survival/infectivity, they are less useful for drugtarget validation. The effectiveness of targeting each pathway enzyme was evaluated by considering (i) the enzyme kinetic properties and antioxidant metabolite concentrations and (ii) the current knowledge and experimental approaches to the study of the control of fluxes and intermediary concentrations in metabolic pathways. The metabolic control analysis indicates that highly potent and specific inhibitors have to be designed for trypanothione reductase and the peroxide detoxification system, and hence other enzymes emerge (γ-glutamylcysteine synthetase, trypanothione synthetase, ornithine decarboxylase, S-adenosylmethionine decarboxylase and polyamine transporters) as alternative more suitable and effective drug targets in the antioxidant metabolism of trypanosomatids.
Keywords: Leishmania, Trypanosoma, trypanothione, drug-targeting, microbial antioxidant metabolism, Trypanosoma brucei, Trypanosoma cruzi, trypanothione [T(SH)2], phenotypic effects, trypanothione reductase, peroxide detoxification system, ?-glutamylcysteine synthetase, ornithine decarboxylase, S-adenosylmethionine decarboxylase, polyamine transporters, leishmaniasis, difluoromethylornithine (DFMO), melarsoprol, sodium stibogluconate, meglumine antimoniate, glycolysis, sterol biosynthesis, protein prenylation, recycle trypanothione [T(SH)2], glutathione reductase (GR), thioredoxin reductases (TrxR), spermidine (Spd), homotrypanothione, Euglena gracilis, Entamoeba histolytica, γ-glutamylcysteine synthetase, carboxyl group of glutamate (Glu), α-amino group of cysteine (Cys), γ-glutamylcysteine (γEC), Glutathione synthetase, trypanosomatids, ABC transporter (pgpa), Plasmodium falciparum, spermidine synthase, decarboxylated Sadenosylmethionine (dAdoMet), heterotetrameric enzyme, oligomeric form, prozyme, T. brucei gambiense, phylogenetic analyses, L. mexicana amastigotes, T(SH)2 Synthesis, stoichiometric, Trypanosoma cruzi TryS (TcTryS), epimastigotes, amastigotes, tryparedoxin (TXN), thioredoxin (Trx), thioredoxin reductase (TrxR), 2-Cys peroxyredoxins (2-Cys-Prx), non-selenium glutathione peroxidase type A (nsGPxA), glutaredoxins (Grx), TXN-dependent peroxidases (TXNPx), cytosolic isoenzyme, endoplasmic reticulum (ER), Thioredoxin, trypanosomal Trxs, dehydroascorbate (DHA), thiol-molecules, Glutathione-S- transferases (GSTs), xenobiotic detoxification, RNA interference (RNAi), ?ECS Inhibition, buthionine sulfoximine, nifurtimo, benznidazole, Metabolic Control Analysis (MCA), nifurtimox, megazol, allosteric modulators, leishmanial parasites, glutathionyl-spermidine, Difluoromethylornithine
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Therapy
Current Drug Delivery
Related Books
Anthocyanins: Pharmacology and Nutraceutical Importance
Computer-Aided Drug Discovery Methods: A Brief Introduction
The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings
Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention
Drug Addiction Mechanisms in the Brain
Software and Programming Tools in Pharmaceutical Research
Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep
Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19
Advanced Pharmacy
40
